# Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection

> **NCT01137292** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 177 (actual)

## Conditions studied

- Invasive Fungal Infections

## Interventions

- **DRUG:** voriconazole (VFEND®)

## Key facts

- **NCT ID:** NCT01137292
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 177 (ACTUAL)
- **Last updated:** 2011-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01137292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01137292, "Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01137292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*